Clinical trial
Comparison of HD Chemotherapy Followed by Auto-transplant and R-CHOP in High…
NCT00355199 · Gruppo Italiano Terapie Innovative nei Linfomi, Other · Completed
Key facts
| NCT number | NCT00355199 |
|---|---|
| Title | Comparison of HD Chemotherapy Followed by Auto-transplant and R-CHOP in High Risk Patients With DLBCL. |
| Official title | Multicentric Randomized Phase III Study Comparing High Doses of Chemotherapy With Rituximab Followed by Auto-transplant HPC Versus CHOP Plus Rituximab as First Line Therapy in High Risk Patients With DLBCL Non-Hodgkin's Lymphomas |
| Lead sponsor | Gruppo Italiano Terapie Innovative nei Linfomi, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Diffuse Large B-Cell Lymphoma |
| Intervention type | Drug |
| Interventions | Rituximab-HDS, Rituximab-CHOP |
| Enrollment | 246 |
| Start date | May 1, 2005 |
| Primary completion | Mar 1, 2013 |
| Completion | Mar 1, 2013 |
| First posted | Jul 21, 2006 |
| Last update posted | Aug 10, 2017 |
| Countries | Italy |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: